Rate My Professor Ian Cook

Cook's research specializations focus on evidence-based vaccination practices, including comparative reactogenicity and immunogenicity of vaccines via intramuscular versus subcutaneous routes, optimal needle lengths and injection sites to prevent adverse events such as shoulder injury related to vaccine administration and lipoatrophy from COVID-19 vaccines. His studies address techniques for infants, toddlers, and elderly adults, ventrogluteal site efficacy, and protocols minimizing medically attended injection-site events. Key publications include 'Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults' (Vaccine, 2007), 'Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults' (Vaccine, 2006), 'Optimal technique for intramuscular injection of infants and toddlers: a randomised trial' (Medical Journal of Australia, 2005), 'Best vaccination practice and medically attended injection site events following deltoid intramuscular injection' (Human Vaccines & Immunotherapeutics, 2015), 'Definition of needle length required for intramuscular deltoid injection in elderly adults: An ultrasonographic study' (Clinical Infectious Diseases, 2006), 'Ventrogluteal area - A suitable site for intramuscular vaccination of infants and toddlers' (European Journal of Clinical Microbiology & Infectious Diseases, 2006), and 'Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine' (Human Vaccines & Immunotherapeutics, 2022). Cook's contributions have advanced safer immunization strategies and public health protocols.